Effectiveness of rescue antiretroviral therapy including intravenously administered zidovudine and foscarnet in a child with HIV-1 enteropathy

被引：0
|
作者：
Hainaut, M
Gérard, M
Peltier, CA
Souayah, H
Mascart, F
Zissis, G
Levy, J
机构：
[1] CHU St Pierre, Dept Paediat, B-1000 Brussels, Belgium
[2] CHU St Pierre, Dept Internal Med, Brussels, Belgium
[3] Free Univ Brussels, Erasme Hosp, Dept Immunol, B-1050 Brussels, Belgium
[4] Free Univ Brussels, AIDS Reference Lab, Brussels, Belgium
来源：
EUROPEAN JOURNAL OF PEDIATRICS | 2003年 / 162卷 / 7-8期
关键词：
D O I：
10.1007/s00431-003-1224-9
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
引用
收藏
页码：528 / 529
页数：2
相关论文
共 50 条
  • [41] LDL SIZE DETERMINANTS DURING ANTIRETROVIRAL THERAPY INCLUDING PROTEASE INHIBITORS IN HIV-1 INFECTED PATIENTS
    Bittar, R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2011, 12 (01) : 29 - 29
  • [42] Early antiretroviral therapy reduces HIV-1 DNA following perinatal HIV-1 infection
    Foster, C.
    Kaye, S.
    Fidler, S.
    Pace, M.
    Jones, M.
    Hopkins, E.
    Robinson, N.
    Frater, J.
    HIV MEDICINE, 2015, 16 : 6 - 6
  • [43] Shortened zidovudine regimens to prevent mother-to-child transmission of HIV-1
    Halpern, SD
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (04): : 307 - 307
  • [44] ZIDOVUDINE TO DECREASE MOTHER-TO-CHILD TRANSMISSION OF HIV-1 - IS IT GOOD FOR DEVELOPING
    DABIS, F
    MANDELBROT, L
    MSELLATI, P
    VANDEPERRE, P
    AIDS, 1995, 9 (02) : 204 - 206
  • [45] Field acceptability and effectiveness of the routine utilization of zidovudine to reduce mother-to-child transmission of HIV-1 in West Africa
    Meda, N
    Leroy, V
    Viho, I
    Msellati, P
    Yaro, S
    Mandelbrot, L
    Montcho, C
    Manigart, O
    Dabis, F
    AIDS, 2002, 16 (17) : 2323 - 2328
  • [46] CESSATION OF ZIDOVUDINE THERAPY MAY LEAD TO INCREASED REPLICATION OF HIV-1
    WAINBERG, MA
    FALUTZ, J
    FANNING, M
    GILL, J
    GELMON, K
    MONTANER, JSG
    OSHAUGHNESSY, M
    TSOUKAS, C
    RUEDY, J
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1989, 261 (06): : 865 - 866
  • [47] Efficacy and safety of zidovudine, lamivudine, and tenofovir combination in antiretroviral naive, HIV-1 infected patients
    Rey, D
    Krebs, M
    Partisani, M
    Hess-Kempf, G
    Cheneau, C
    Priester, M
    Bernard-Henry, C
    De Mautort, E
    Lang, JM
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 : S120 - S120
  • [48] Onset of HIV-1 antibody production after highly active antiretroviral therapy in a seronegative HIV-infected child
    De Rossi, A
    Giaquinto, C
    Del Mistro, A
    Zamarchi, R
    Chieco-Bianchi, L
    AIDS, 2000, 14 (09) : 1284 - 1286
  • [49] HIV-1 seroreversion following antiretroviral therapy in an HIV-infected child initially presenting with acquired immunodeficiency syndrome
    Neubert, Jennifer
    Laws, Hans-Juergen
    Adams, Ortwin
    Muenk, Carsten
    Kraemer, Melanie
    Niehues, Tim
    Korn, Klaus
    Fleckenstein, Bernhard
    Petri, Edmund
    Borkhardt, Arndt
    AIDS, 2010, 24 (02) : 327 - 328
  • [50] ZALCITABINE COMPARED WITH ZIDOVUDINE IN PATIENTS WITH ADVANCED HIV-1 INFECTION WHO RECEIVED PREVIOUS ZIDOVUDINE THERAPY
    FISCHL, MA
    OLSON, RM
    FOLLANSBEE, SE
    LALEZARI, JP
    HENRY, DH
    FRAME, PT
    REMICK, SC
    SALGO, MP
    LIN, AH
    NAUSSKAROL, C
    LIEBERMAN, J
    SOO, WJ
    ANNALS OF INTERNAL MEDICINE, 1993, 118 (10) : 762 - 769
12345